BitradeX Secures £12 Million Series A to Accelerate Global Expansion of AI-Powered Trading Infrastructure

LONDON--(BUSINESS WIRE)--Apr 22, 2025--

BitradeX, a next-generation AI-powered digital asset trading platform, has announced the successful completion of its £12 million Series A funding round, led by Bain Capital. The capital will support BitradeX’s global compliance expansion, the development of its AI Strategy Labs, and continued investment in its core technology stack.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250422795346/en/

Founded in 2022, BitradeX is committed to redefining the digital asset trading experience through intelligent automation, rigorous compliance, and a user-first design. The platform is best known for its proprietary ARK Trading Model, an AI-native engine built on trillion-parameter architectures that integrates advanced techniques from DeepSeek and Qianfan for high-frequency crypto trading.

The ARK model currently achieves over 90% short-term trend prediction accuracy and has delivered annualized returns of 120%–180% in live market conditions. By combining real-time on-chain activity, macro data, sentiment indicators, and market volatility, ARK executes trades with millisecond latency and dynamic risk calibration.

In a major innovation, BitradeX introduced the industry's first AI-yield-powered Protection Pool, a dual-layer mechanism that autonomously absorbs losses and redistributes excess yields to ensure principal and fixed-income coverage. Unlike traditional insurance-based exchanges, BitradeX embeds capital protection directly into its reward model. The Protection Pool is publicly auditable and seeded with 100 BTC in reserve capital.

On the compliance front, BitradeX holds both a UK FCA crypto license and a US MSB license, operating under institutional-grade custody frameworks, a five-tier risk control system, and a $20 million contingency reserve. These measures enable BitradeX to offer transparent, secure, and compliant services to retail and professional users alike.

Looking ahead, the platform plans to launch AI Strategy Labs in key markets including London, Hong Kong, and Singapore within the next 6 months. These hubs will allow developers and institutions to access and customize the ARK model through open APIs under a “Strategy-as-a-Service” framework — opening the door to fully modular and programmable crypto trading systems.

BitradeX is positioning itself as the infrastructure layer for the next generation of AI-native finance, delivering predictable performance, automated execution, and built-in protection — all on a globally compliant foundation. If you're interested in collaborating or communicating with Bitradex, please contact us at support@bitradex.com.

BitradeX Secures £12 Million Series A to Accelerate Global Expansion of AI-Powered Trading Infrastructure

WELLINGTON, New Zealand (AP) — A New Zealand professional rugby player who died by suspected suicide last year had advanced chronic traumatic encephalopathy (CTE), a brain abnormality linked to repeated concussions, according to a post-mortem examination.

The diagnosis was announced Thursday by Coroner Ian Telford, who is conducting a preliminary hearing into the death of Shane Christie who died in August aged 39.

CTE is a disease which causes progressive damage to brain tissue and has been known to cause mood swings, impulsive behavior and depression, among other symptoms. It can only be diagnosed after death.

Christie was a former New Zealand Maori representative who believed he was suffering from CTE and campaigned for greater understanding of the condition after the death of his friend and fellow rugby professional Billy Guyton, also by suspected suicide.

The abnormality has also been linked to deaths in the National Football League and in other contact sports such as hockey and soccer.

Friends and family of Christie said he wanted his diagnosis made public to raise awareness of CTE for players suffering its symptoms.

Christie who played Super Rugby for the Crusaders and Highlanders retired from rugby in 2018, suffering the effects of repeated concussions.

The coroner said pathologist Dr. Clinton Turner had confirmed “the diagnosis of chronic traumatic encephalopathy (CTE), which he characterizes as ‘high stage’.” Turner works at the University of Auckland “brain bank” to which Guyton and Christie had donated their brains.

The coroner said the diagnosis was the pathologist's opinion and that the cause of Christie's death would be determined by the coronial process.

The chief executive of New Zealand Rugby, Steve Lancaster told New Zealand media his organization recognizes “an association between repeated head impacts and CTE and takes this issue seriously.”

“New Zealand Rugby acknowledges the CTE pathology results for Shane Christie confirmed by The Neurological Foundation Human Brain Bank. We also acknowledge and respect the role of the coroner to determine the nature of any inquiry they may hold examining the cause and circumstances of Shane’s passing,” Lancaster said.

“We share the concerns about the potential long-term effects of repeated head knocks in rugby and support the need for ongoing research into this."

AP rugby: https://apnews.com/hub/rugby

Highlanders player Shane Christie, center, gets into space during the Round 16 Super Rugby match between the Queensland Reds and the Highlanders at Suncorp Stadium in Brisbane, Australia on May 30, 2014. (Dave Hunt/AAP Image via AP)